study objective : to evaluate the toxicity , effects on immune function , antitumor effects , antiretroviral effects , and pharmacokinetics of zidovudine therapy in patients with early human immunodeficiency virus ( hiv ) infection and kaposi sarcoma .
C0009450
infection
C0036220
kaposi